Vladimir Lerner, MD, PhD

Original Research

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

December 15, 2013

Vladimir Lerner, Chanoch Miodownik, Anatoly Gibel, et al

Original Research

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

November 30, 2010

Michael S. Ritsner, Chanoch Miodownik, Yael Ratner, et al

Original Research

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

June 15, 2010

Michael S. Ritsner, Anatoly Gibel, Tatyana Shleifer, et al

Original Research

Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

November 15, 2007

Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al

Original Research

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

July 16, 2007

Igor Libov, Chanoch Miodownik, Yuly Bersudsky, et al

Original Research

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

August 15, 2006

Chanoch Miodownik, Vladimir Lerner, Adi Kibari, et al

Original Research

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

December 15, 2005

Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al

Original Research

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

January 15, 2005

Joseph Bergman, Tzvi Dwolatzky, Izidor Brettholz, et al

Original Research

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

November 1, 2004

Vladimir Lerner, Joseph Bergman, Nikolay Statsenko, et al

Original Research

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

January 1, 2002

Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al

Letter to the Editor

Nefazodone-Associated Subjective Complaints of Burning Sensations

August 31, 2000

Vladimir Lerner, Michael A. Matar, Inessa Polyakova

Letter to the Editor

Movement Disorders and Psychotic Symptoms Treated With Pyridoxine: A Case Report

November 15, 1998

Vladimir Lerner, Mark Liberman

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

Nefazodone-Associated Subjective Complaints of Burning Sensations

Movement Disorders and Psychotic Symptoms Treated With Pyridoxine: A Case Report

ELSEWHERE:

FOLLOW US:

Vladimir Lerner, MD, PhD

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder: An 8-Week, Double-Blind, Randomized, Controlled, 2-Center, Parallel-Group Trial

Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Beneficial Effect of Donepezil in the Treatment of Elderly Patients With Tardive Movement Disorders

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

Nefazodone-Associated Subjective Complaints of Burning Sensations

Movement Disorders and Psychotic Symptoms Treated With Pyridoxine: A Case Report

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles